Appointment of Resolution Professional in place of Interim Resolution Professional
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Minute windows have no benchmark: there is no intraday index history to compare against.
Supha Pharmachem Limited, currently under Corporate Insolvency Resolution Process (CIRP), has received NCLT approval to appoint Mr. Raju Mangilal Marshiya as the Resolution Professional, replacing the Interim Resolution Professional. The NCLT Mumbai Bench passed the order on April 30, 2026, based on a resolution passed by the Committee of Creditors (CoC) with 67.28% voting share. The CoC consists of Operational Creditors as there are no Financial Creditors in this case. Mr. Raju Mangilal Marshiya has taken over the conduct of CIRP, and the powers of the Board of Directors remain suspended. The company was admitted to CIRP based on a petition filed by Operational Creditor Boston Ivy Healthcare Solutions Private Limited under Section 9 of the Insolvency and Bankruptcy Code, 2016.
The replacement of the IRP with a permanent RP indicates the insolvency resolution process is progressing. The stock remains suspended from trading, and shareholders should expect continued uncertainty until a resolution plan is approved or the company faces liquidation.